Modulation of blood brain barrier protein expression
US8466118B2 · kind B2 · utility
8Cited by
6References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 23, 2008 |
| Grant date | Jun 18, 2013 |
| Priority date | — |
| Expiry date | Dec 14, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/31
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
There are disclosed agents that inhibit Blood Brain Barrier Proteins (BBBP). Such agents are useful in controlling agents entering and exiting the CNS. This allows for drugs to be more effective and/or allowing side effects of the drugs to be lowered.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.